Seòmar agus comataidhean

Booster vaccinations in Scotland started as soon as possible once the Joint Committee on Vaccination and Immunisation (JCVI) provided their advice on boosters, which stated that the booster dose should be offered no earlier than six months after completion of the primary vaccine course, however there is some flexibility to offer a booster vaccination to the most vulnerable groups after five months.

1,342,841 people have received a booster or 3rd dose to 19 November, and we are working as quickly as we can, prioritising those most vulnerable.

Data on boosters by JCVI priority group is not yet published. We continue to work closely with Public Health Scotland to develop the vaccination data to provide robust statistics that enhance public understanding.

Booster vaccinations in Scotland started as soon as possible once the Joint Committee on Vaccination and Immunisation (JCVI) provided their advice on boosters, which stated that the booster dose should be offered no earlier than six months after completion of the primary vaccine course, however there is some flexibility to offer a booster vaccination to the most vulnerable groups after five months.

1,342,841 people have received a booster or 3rd dose to Friday 19 November, and we are working as quickly as we can, prioritising those most vulnerable.

Data on boosters by JCVI priority group is not yet published. We continue to work closely with Public Health Scotland to develop the vaccination data to provide robust statistics that enhance public understanding.

Booster vaccinations in Scotland started as soon as possible once the Joint Committee on Vaccination and Immunisation (JCVI) provided their advice on boosters, which stated that the booster dose should be offered no earlier than six months after completion of the primary vaccine course, however there is some flexibility to offer a booster vaccination to the most vulnerable groups after five months.

1,342,841 people have received a booster or 3rd dose to 19 November, and we are working as quickly as we can, prioritising those most vulnerable.

Data on boosters by JCVI priority group is not yet published. We continue to work closely with Public Health Scotland to develop the vaccination data to provide robust statistics that enhance public understanding.

Booster vaccinations in Scotland started as soon as possible once the Joint Committee on Vaccination and Immunisation (JCVI) provided their advice on boosters, which stated that the booster dose should be offered no earlier than six months after completion of the primary vaccine course, however there is some flexibility to offer a booster vaccination to the most vulnerable groups after five months.

1,342,841 people have received a booster or 3rd dose to 19 November, and we are working as quickly as we can, prioritising those most vulnerable.

Data on boosters by JCVI priority group is not yet published. We continue to work closely with Public Health Scotland to develop the vaccination data to provide robust statistics that enhance public understanding.

The SPCB is responsible for funding the Members’ Expenses Scheme and for determining which indices are used to uprate the overall provisions, which include staff cost provision.

At the SPCB meeting on 5 March 2020, the SPCB agreed to index SCP annually using a mix of Average Weekly Earnings (AWE) and the Annual Survey of Hours and Earnings (ASHE) index. This move to a ‘basket’ of indices was considered to provide a steadier basis for any increase as fluctuations are more likely to be moderated. SPCB agreed that this approach should be adopted for future indexation of staff cost provision as a transparent means of determining any increase. There has been no change in this position.

This index is now used as part of the budget setting process and part of our submission to the Finance Committee for the next financial year.

Prior to the start of the new parliamentary session, an in-depth review of the Staff Cost Provision was undertaken. The report on the Review of the Members’ Staff Cost Provision was finalised and circulated to all Members in December 2020. This resulted in a change from the start of Session 6 where members would benefit from increased funding equivalent to one additional FTE staff member.

The SPCB undertakes Members’ Expenses Scheme reviews each session to ensure that the Expenses Scheme continues to support Members in carrying out their roles and to identify where there are any beneficial improvements to the Scheme which could assist Members whilst continuing to maintain the principles and transparency associated with the Scheme. Given the Scheme, including the Staff Cost Provision, has recently been reviewed the SPCB will consider the need for any further review later in the parliamentary session as part of their normal review processes.

Booster vaccinations in Scotland started as soon as possible once the Joint Committee on Vaccination and Immunisation (JCVI) provided their advice on boosters, which stated that the booster dose should be offered no earlier than six months after completion of the primary vaccine course, however there is some flexibility to offer a booster vaccination to the most vulnerable groups after five months.

1,342,841 people have received a booster or 3rd dose to 19 November, and we are working as quickly as we can, prioritising those most vulnerable.

Data on boosters by JCVI priority group is not yet published. We continue to work closely with Public Health Scotland to develop the vaccination data to provide robust statistics that enhance public understanding.

I have asked Teresa Medhurst, Interim Chief Executive of the Scottish Prison Service (SPS), to respond. Her response is as follows:

The SPS does not hold the requested data. Since 2013, SPS has asked all persons on admission to custody to self-declare any known disability. The response is recorded on SPS’ internal system as either: yes, no or prefer not to disclose. However, the type of disability it is not specifically recorded.

Every individual in SPS custody is interviewed by a Healthcare Professional on admission in order to assess their healthcare needs. Where there is an identified need for additional support or reasonable adjustments whilst in custody, SPS, NHS and our education service partners will work in partnership to facilitate this.

I have asked Teresa Medhurst, Interim Chief Executive of the Scottish Prison Service (SPS), to respond. Her response is as follows:

The SPS does not hold the requested data. Since 2013, SPS has asked all persons on admission to custody to self-declare any known disability. The response is recorded on SPS’ internal system as either: yes, no or prefer not to disclose. However, the type of disability it is not specifically recorded.

Every individual in SPS custody is interviewed by a Healthcare Professional on admission in order to assess their healthcare needs. Where there is an identified need for additional support or reasonable adjustments whilst in custody, SPS, NHS and our education service partners will work in partnership to facilitate this.

NHS Boards are expected to ensure that patients, including those living with severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) have access to a range of professionals to provide the appropriate management of their condition. We would further expect clinicians to have good awareness of guidance relevant to their practice area and apply these taking account of individual circumstances and discussions with the patient.

In light of the final National Institute for Health and Care Excellence (NICE) guideline for ME/CFS being published, we are considering how best to review and update existing Scottish guidance, and will be reviewing the need for specialist services as part of this work.

We are regularly engaging with our stakeholders, including the third sector, people with lived experience and clinicians working in this area, to drive forward care and the development of pathways. We plan to undertake a structured programme of stakeholder engagement in early 2022 to initiate the revision of Scottish guidance and to identify opportunities for improvement.

We have recently supported the creation of a Priority Setting Partnership by the James Lind Alliance and Action for M.E. to agree the top 10 priorities for future research on ME/CFS. This approach brings patients, carers and clinicians together to identify and prioritise research uncertainties in the field of ME/CFS, before disseminating the results to research funders.

We are investing £4.5 million of funding to implement the Neurological Care and Support Framework. Commitment 13 of the Neurological Care and Support Framework involves supporting neurological research, and we welcome proposals for ME/CFS research.

I refer the member to the answer to question S6W-04189 on 22 November 2021. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers.